# Efficacy of Colchicine in Preventing Recurrent Stroke in the Patients With Acute Atherothrombotic Ischemic Stroke During Hospitalization

Study · id `cardio:ct-nct06102720` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06102720](<https://clinicaltrials.gov/study/NCT06102720>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06102720

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT06102720. Randomized; no masking; primary purpose treatment. Start 2023-01-12 (actual); primary completion 2025-01-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT06102720, source copy `cardio:ctgov-nct06102720-2023-11-07`, retrieved 2026-10-26)
- Started: 2023-01-12 (actual) (ClinicalTrials.gov record NCT06102720, source copy `cardio:ctgov-nct06102720-2023-11-07`, retrieved 2026-10-26)
- Primary completion: 2025-01-01 (anticipated) (ClinicalTrials.gov record NCT06102720, source copy `cardio:ctgov-nct06102720-2023-11-07`, retrieved 2026-10-26)
- Completion: 2025-02-01 (anticipated) (ClinicalTrials.gov record NCT06102720, source copy `cardio:ctgov-nct06102720-2023-11-07`, retrieved 2026-10-26)
- Countries: Russia (ClinicalTrials.gov record NCT06102720, source copy `cardio:ctgov-nct06102720-2023-11-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06102720-2023-11-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy of Colchicine in Preventing Recurrent Stroke in the Patients With Acute Atherothrombotic Ischemic Stroke During Hospitalization
- Acronym: COLCHIDA
- Condition: Ischemic Stroke
- Intervention (Drug): Colchicine
- Intervention (Drug): Clopidogrel
- Lead sponsor: Mikhail Zykov
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Colchicine (`cardio:colchicine`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)

## Provenance

Content hash: 13698f7729792a8b8c89dcfe42f7ed089addaec6fefffb6b783bab4ccab4ca60
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
